Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study - Top-Institutions - MDSpire

Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study

  • By

  • Lukas Böck

  • Katharina Kerschan-Schindl

  • Martin Frossard

  • Stefan Hajdu

  • Richard Crevenna

  • Martina Anditsch

  • Gunar Stemer

  • Anna Antoni

  • July 3, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Austrian Society for Bone and Mineral Metabolism
    Austrian Society for Bone and Mineral Metabolism

    Vienna, Austria

    Key Differentiators

    • Endocrinology

  • #2

    tertiary academic trauma center
    tertiary academic trauma center

    Unknown, Unknown

    Key Differentiators

    • Trauma Surgery
    • Endocrinology

Original Source(s)

Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study

  • by Lukas Böck, Katharina Kerschan-Schindl, Martin Frossard, Stefan Hajdu, Richard Crevenna, Martina Anditsch, Gunar Stemer, Anna Antoni

  • July 3, 2026

Related Content

Body composition’s effect on the bone–vascular axis of osteoporosis discovered in AI-based CT analysis of COPD patients

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Lower BMI, Lower Joint Replacement Risk?

Researchers urge caution in interpreting joint replacement predictors, noting that surgery reflects access and decision-making as well as disease biology.